Myra Dove, MD
Obstetrics & Gynecology · Ketchikan, AKNPI 1124025655
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,143 of the $1,898 with a category attached, or 60.2%. Intuitive Surgical accounts for 60.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $1,160 and has fallen 91.8% since, to $95 in 2025.
Across 36 payments — averaging $52.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Minerva Surgical, Inc$182
- Daiichi Sankyo Inc.$125
- Mayne Pharma Commercial LLC$79
- Sumitomo Pharma America, Inc.$43
- Hologic Sales And Service, LLC$42
- plus $284 from 12 others
What the payments were for
- Travel & lodging$1,14360%
- Food & beverage$73739%
- Education$171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $1,143 |
| Minerva Surgical, Inc | 5 | $182 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Mayne Pharma Commercial LLC | 4 | $79 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Hologic Sales And Service, LLC | 3 | $42 |
| AbbVie | 3 | $41 |
| Evofem Biosciences, Inc. | 3 | $36 |
| Roche Diagnostics Corporation | 2 | $33 |
| Exeltis, USA Inc. | 2 | $30 |
| Merck | 2 | $25 |
| Biogen | 1 | $22 |
| Exact Sciences | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $13 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,898 in reported general payments places this provider in the 80th percentile of 97 obstetrics & gynecology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $1,224 |
| Clobetasol Propionate | 12 | $321 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Ketchikan
- Christy SouthPalmer$19K
- Nicholas NewburyJuneau$9K
- Melissa TondreAnchorage$9K
- Kathryn OstromHomer$9K
- Patricia CapoAnchorage$9K
- Shiloh SmallAnchorage$9K
- John HoughtonPalmer$7K
- Allison van HaastertAnchorage$6K
- Natalia SaprykinaAnchorage$6K
- Jessica GoldbergerAnchorage$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.